Serine/threonine kinases as molecular targets of antidepressants: implications for pharmacological treatment and pathophysiology of affective disorders

M Popoli

Open source

DOI
10.1016/s0163-7258(00)00108-x
Published
2001-02
Container
Pharmacology & Therapeutics
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0163-7258-00-00108-x,
  title = {Serine/threonine kinases as molecular targets of antidepressants: implications for pharmacological treatment and pathophysiology of affective disorders},
  author = {M Popoli},
  year = {2001},
  journal = {Pharmacology \& Therapeutics},
  doi = {10.1016/s0163-7258(00)00108-x},
  url = {https://doi.org/10.1016/s0163-7258(00)00108-x}
}

RIS

TY  - JOUR
TI  - Serine/threonine kinases as molecular targets of antidepressants: implications for pharmacological treatment and pathophysiology of affective disorders
AU  - M Popoli
PY  - 2001
JO  - Pharmacology & Therapeutics
DO  - 10.1016/s0163-7258(00)00108-x
UR  - https://doi.org/10.1016/s0163-7258(00)00108-x
ER  - 

APA

Popoli, M. (2001). Serine/threonine kinases as molecular targets of antidepressants: implications for pharmacological treatment and pathophysiology of affective disorders. Pharmacology & Therapeutics. https://doi.org/10.1016/s0163-7258(00)00108-x

Source records